HYBRIGENICS SERVICES – Trademark Portfolio

Entity Type: 34

HYBRIGENICS SERVICES holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 5 Nice Classification classes. The owner is based in PARIS.

3-5 IMPASSE REILLE

PARIS 75014 , FR

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

HYBRIGENICS SERVICES's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (5 filings)

Scientific and technological services; industrial analysis and research services

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

38
Telecommunications (1 filing)

Telecommunications

Frequently Asked Questions

How many trademarks does HYBRIGENICS SERVICES have?

HYBRIGENICS SERVICES has 5 U.S. trademarks filed with the USPTO.

What trademark classes does HYBRIGENICS SERVICES file in?

HYBRIGENICS SERVICES files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.

What is HYBRIGENICS SERVICES's trademark registration success rate?

HYBRIGENICS SERVICES has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.